By Kate Greenwood
In Food and Drug Administration (FDA)
May 21st, 2012
Last week, the United States Senate took up debate of The Food and Drug Innovation and Safety Act, S 3187. A similar bill, HR 5651, was voted out of the House Energy and Commerce committee earlier this month. In addition to re-authorizing user fees for drug and devices and newly authorizing user fees for biologics […]...